日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry

边缘区淋巴瘤患者特征和治疗结果:德国前瞻性MZL登记研究的结果

Grunenberg, Alexander; Schmelzle, Birgit; Gökeler, Jacqueline; Mund, Heike; Viardot, Andreas; Dreyhaupt, Jens; Nagel, Gabriele; Reiser, Marcel; Gabrysiak, Thomas; Braulke, Friederike; Dunst, Jürgen; Schlag, Rudolf; Gaska, Tobias; Runde, Volker; Kraemer, Doris; Weber, Thomas; Mueller, Lothar; Johansson, Patricia; Ziske, Carsten; Hess, Georg; Liersch, Rüdiger; Buske, Christian

Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)

来自德国前瞻性 PARAGON(胰腺癌结果、生活质量和转化研究平台)注册研究(IKF-PARAGON 研究)的胰腺癌患者一线至三线治疗情况和生活质量数据

Goetze, Thorsten O; Al-Batran, Salah-Eddin; Liersch, Ruediger; Scheuer, Lars; Goehler, Thomas; Kaiser, Ulrich; Denzlinger, Claudio; Brandl, Stephan; Pink, Daniel; Uhlig, Jens; Maasberg, Michael; Loose, Maria; Schaaf, Marina; Sookthai, Disorn; Zäpf, Bianca; Pauligk, Claudia; Habibzade, Timursah; Hofheinz, Ralf-Dieter; Koch, Christine

Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

阿卡替尼治疗老年(≥80岁)和/或体弱的慢性淋巴细胞白血病患者:CLL-Frail试验的主要终点分析

Simon, Florian; Ligtvoet, Rudy; Bohn, Jan-Paul; Nösslinger, Thomas; von Tresckow, Julia; Liersch, Rüdiger; Gaska, Tobias; Jentsch-Ullrich, Kathleen; Gärtner, Michael; Wolff, Thomas; Schwaner, Ingo; Wolf, Dominik; Schneider, Christof; Vehling-Kaiser, Ursula; Ritgen, Matthias; Spoer, Christian; Eckart, Michael; Decker, Thomas; Chakupurakal, Geothy; Schöttker, Björn; Kisro, Jens; Kreuzer, Karl-Anton; Tausch, Eugen; Stilgenbauer, Stephan; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Fürstenau, Moritz; Fischer, Kirsten; Goede, Valentin; Hallek, Michael; Eichhorst, Barbara

Cytogenetic signatures favoring metastatic organotropism in colorectal cancer

结直肠癌转移性器官趋向性的细胞遗传学特征

Golas, Mariola Monika; Gunawan, Bastian; Gutenberg, Angelika; Danner, Bernhard C; Gerdes, Jan S; Stadelmann, Christine; Füzesi, Laszlo; Liersch, Torsten; Sander, Bjoern

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

德国淋巴瘤联盟开展的一项II期研究结果显示,伊布替尼联合奥妥珠单抗治疗未经化疗的晚期滤泡性淋巴瘤疗效显著。

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Erratum to: "Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance"

更正:“伊布替尼和奥妥珠单抗联合治疗未经治疗的晚期滤泡性淋巴瘤:德国淋巴瘤联盟 II 期研究的结果”

Schmidt, Christian; Scheubeck, Gabriel; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Rüdiger; Dürig, Jan; Pott, Christiane; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang

Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial

在德国,帕博西尼联合芳香化酶抑制剂或氟维司群治疗晚期 HR+/HER2- 乳腺癌患者:II 期多队列 INGE-B 试验的最终结果

Welslau, Manfred; Potthoff, Karin; Zaiss, Matthias; Müller, Lothar; Brucker, Cosima; Salat, Christoph; Untch, Michael; Meiler, Johannes; Lüftner, Diana; Welt, Anja; Dörfel, Steffen; Hagen, Volker; Stein, Alexander; Liersch, Rüdiger; Kuhn, Thomas; Siebenbach, Hans Ulrich; Bing, Gerlinde; Vannier, Corinne; Marschner, Norbert; Gratzke, Katja

Evaluating ChatGPT-4o as an Educational Support Tool for the Emergency Management of Dental Trauma: Randomized Controlled Study Among Students

评估 ChatGPT-4o 作为牙科创伤急救教育支持工具的有效性:一项针对学生的随机对照研究

Haupt, Franziska; Rödig, Tina; Liersch, Paula

Establishing a telemedical supported trans-sectoral collaboration network from community support to emergency care for outpatient care recipients: study protocol of a prospective non-randomized complex intervention study with a pragmatic approach, Stay@Home - Treat@Home

建立从社区支持到门诊患者紧急护理的远程医疗支持的跨部门协作网络:一项采用实用方法的前瞻性非随机复杂干预研究“居家治疗”(Stay@Home - Treat@Home)的研究方案

Müller, Doreen; Jachan, Deborah Elisabeth; Stahl, Maria; Rosenbusch, Marie-Luise; Liersch-Mazan, Daniela; Lippert, Peggi; Hinricher, Niels; Ivanova, Maria; Schulz, Mandy; Lahmann, Nils

Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

RIBBIT研究的最终结果:一项随机III期研究,旨在评估一线治疗中接受瑞博西尼联合内分泌治疗或化疗(伴或不伴贝伐珠单抗)的转移性激素受体阳性、HER2阴性乳腺癌患者的疗效和生活质量。

Decker, Thomas; Zaiss, Matthias; Klein, Dunja; Hahn, Antje; Hagen, Volker; La Rosée, Paul; Liersch, Rüdiger; Wolff, Thomas; Niemeier, Beate; Hillebrand, Larissa E; Lennartz, Carolin; Chiabudini, Marco; Bengsch, Fee; Indorf, Martin; Marschner, Norbert